EUVIMEDΑνακαλύψτε το EUVIMED
Scoping ReviewOpen access

Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review

Telehealth-Nutzung und rechtliche Aspekte in Drug-Health-Services während Pandemien: systematisches Scoping-Review

Meryem Jefferies iD, Robert Graham iD, Marguerite Tracy iD, Scott Read iD, Mohammed Eslam iD, Mark W Douglas iD, Jacob George iD

Journal of Medical Internet Research · 2024-11-12 · 26 · e46394

DOI: 10.2196/46394 ↗

Auf einen Blick

Das Review beschreibt rechtliche Aspekte der Telehealth-Versorgung von Patient:innen mit Substanzgebrauchsstörung in Drug-Health-Services. Thematisiert wurden u. a. Einwilligung, Vertraulichkeit, Datenschutz und Haftung.

Fragestellung

Welche rechtlichen Auswirkungen haben Autonomie, Einwilligung, Vertraulichkeit, Privatsphäre, Datensicherheit, Berufshaftpflicht und Haftung bei Telehealth für Patient:innen mit Substanzgebrauchsstörung?

Methode

Systematisches Scoping-Review; Suche in 6 medizinischen und 6 juristischen Datenbanken sowie nach australischen und internationalen Standards; medizinische Artikel bis Juni 2022.

Ergebnisse

80 veröffentlichte Studien erfüllten die Einschlusskriterien. 43 Rechtsdokumente wurden mit 15 Statuten, 4 Fallentscheidungen und 37 medizinischen Publikationen geprüft; häufige Themen waren Einwilligung/Autonomie, Vertraulichkeit, Privatsphäre, Datensicherheit und Berufshaftpflicht.

Einschränkungen

Wenig Diskussion oder Evidenz dazu, wie rechtliche Aspekte in Telehealth-Konsultationen in Drug-Health-Services tatsächlich angewandt werden.

Schlussfolgerung der Autor:innen

Die Autor:innen berichten potenzielle rechtliche Probleme bei Telehealth für Patient:innen mit Substanzgebrauchsstörung und betonen, dass Behandler:innen die medizinrechtlichen Implikationen kennen sollten.

Kernaussagen

  • 80 Studien erfüllten die Einschlusskriterien
  • Häufige Themen: Einwilligung, Vertraulichkeit, Privatsphäre, Datensicherheit
  • Wenig Evidenz zur praktischen Anwendung rechtlicher Vorgaben

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Scoping Review in Journal of Medical Internet Research, published online on 2024-11-12. Written by Meryem Jefferies and 6 co-authors. Institution: Drug Health, Western Sydney Local Health District, North Parramatta, NSW, Australia. Major MEDLINE topics: Telemedicine, COVID-19, Confidentiality, Pandemics. Cited 5 times so far (Crossref); 80 references. The full text is freely available in PubMed Central.

Auf einen BlickΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

Background

The COVID-19 pandemic impacted patients with substance use disorder (SUD) more than the general population and resulted in substantially increased emergency department admissions. Routine care of patients attending drug health services during the pandemic transitioned, with telehealth being important in delivering appropriate care. However, telehealth introduces unique risks such as privacy, confidentiality, and data safety. Providing health care through telehealth may fail if the legal impacts are not fully identified and acted on by health professionals. It also poses unintended risks for patients and can result in ineffectiveness, damages, medical negligence, and detracts from the best intentions of governments and health professionals. Understanding the legal framework ensures that medical professionals operate health care through telehealth within the law. Providing health care successfully through telehealth depends on the balance between innovation and legal compliance. By considering these aspects, clinicians and practitioners can provide effective and safe telehealth services during pandemics or any other natural disaster.

Objective

We aimed to explore the legal impact of autonomy consent, confidentiality, privacy, data security, professional indemnity, and liability when delivering telehealth to patients with SUD. The scoping review also aimed to provide legal, ethical, and clinical considerations to minimize legal risks with using telehealth in drug health service outpatient settings.

Methods

We performed a scoping review to provide an overview of existing research, statutes, and case laws for the incorporation of clinical, ethical, and legal considerations into telehealth use. Six databases for medical and 6 databases for legal publications were searched, as well as Australian national and selected international regulatory standards. Medical articles published up to June 2022 were included in this review. Our search yielded 1436 publications, 614 abstracts were reviewed, and 80 published studies met the inclusion criteria from 614 legal and medical search results. Current regulations related to technology use in drug health services, relevant cases, and international regulatory standards are discussed.

Results

In total, 43 legal documents including 15 statutes, 4 case laws, and 37 medical publications were reviewed. The themes arising from the literature were consent and autonomy (20/80, 25%), confidentiality (8/80, 10%), privacy (8/80, 10%), data security (7/80, 9%), and professional indemnity issues (3/80, 4%) in telehealth use. Further, 24 studies identified legal issues associated with telehealth use in patients with SUD.

Conclusions

Our review identified potential legal issues associated with telehealth use in patients with SUD. Several legal and medical research articles provide frameworks, codes of conduct, or suggestions for clinicians to consider, but there was little discussion or evidence of how legal considerations are being applied when providing telehealth consultations at drug health services. Clinicians should be aware of the medicolegal implications when providing health care via telehealth at drug health services.

Subjects

MeSH terms (MEDLINE)

TelemedicineCOVID-19ConfidentialityPandemicsSubstance-Related DisordersHumansSARS-CoV-2Liability, LegalComputer Security

Author keywords

confidentialityconsentdata securitydrug addictionemergency department admissionprivacyprofessional indemnitysubstance use disordertelehealth use

Authors and institutions

  • Drug Health, Western Sydney Local Health District, North Parramatta, NSW, Australia.
  • Storr Liver Centre, The Westmead Institute for Medical Research, The University of Sydney at Westmead Hospital, Westmead, NSW, Australia.
  • General Practice Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney NSW, Australia.
  • Blacktown/Mt Druitt Clinical School and Research Centre, School of Medicine, Western Sydney University, Blacktown, NSW, Australia.
  • Blacktown Hospital, Western Sydney Local Health District, Blacktown, NSW, Australia.
  • Centre for Infectious Diseases and Microbiology, Sydney Infectious Diseases Institute, The University of Sydney at Westmead Hospital, Westmead, Australia.

ORCID profiles: Meryem Jefferies, Robert Graham, Marguerite Tracy, Scott Read, Mohammed Eslam, Mark W Douglas, Jacob George

Cite

APA

Jefferies, M., Graham, R., Tracy, M., Read, S., Eslam, M., Douglas, M. W., & George, J. (2024). Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review. Journal of Medical Internet Research, 26, e46394. https://doi.org/10.2196/46394

Vancouver

Jefferies M, Graham R, Tracy M, Read S, Eslam M, Douglas MW, et al. Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review. Journal of Medical Internet Research. 2024;26:e46394. doi:10.2196/46394

BibTeX
@article{Jefferies2024,
  author = {Jefferies, Meryem and Graham, Robert and Tracy, Marguerite and Read, Scott and Eslam, Mohammed and Douglas, Mark W and George, Jacob},
  title = {Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review},
  journal = {Journal of Medical Internet Research},
  year = {2024},
  volume = {26},
  pages = {e46394},
  doi = {10.2196/46394}
}
Start for free →